Integrated Platform Opportunity Revvity Signals One offers an end to end cloud native platform that spans the Design Make Test Decide lifecycle across biology, chemistry and materials. This creates opportunities to upsell to existing Revvity customers already using ChemDraw and E Notebook by expanding their workflows into Signals One and enabling cross disciplinary collaboration. Position as a digital transformation partner for pharma, biotech, and chemical development programs, highlighting seamless data analytics via the Spotfire integration to accelerate discovery and decision making.

AI Analytics Partnerships Leverage recent integrations with AI and ML partners such as Intellegens to offer AI enabled experimentation and predictive analytics within Signals Notebook and Signals One. Propose co selling with ML vendors and system integrators to deliver ML driven design optimization, enabling faster go no go decisions in drug discovery and materials development. This can also attract CROs and academic partners seeking scalable AI infused lab data platforms.

Suite Cross Sell Capitalize on Revvity's portfolio by cross selling Signals features to existing customers using ChemDraw and E Notebook, expanding into Signals One for end to end workflow management. Highlight acquisitions and integrations with ACD Labs to offer more comprehensive analytical characterization and design tools, creating a one stop platform for R and D. Build a tiered expansion plan aligned to customers R and D intensity and regulatory needs.

Clinical Trial Acceleration Emphasize Signals One and Spotfire powered analytics as a solution to accelerate clinical trials through real time data visualization and integrated biology chemistry workflows. Target pharma and CROs seeking to shorten trial timelines and improve data quality, with a focus on regulatory compliant cloud deployment and secure data governance. Leverage industry events and partner ecosystems to demonstrate AI enabled lab automation benefits in trials.

Global Partner Expansion Push for a broader partner ecosystem leveraging recent collaborations with Intellegens and ACD Labs as proof points for a scalable integration first strategy. Target Europe and other regions through co marketing with system integrators analytics vendors and CRO networks using events such as Nexus Europe to drive awareness. Offer co development and resale agreements to accelerate adoption across mid market and enterprise pharma biotech and chemical companies.